Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W1TU
|
||||
Former ID |
DNC001646
|
||||
Drug Name |
SB-699551-A
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 5A receptor | Target Info | Antagonist | [1] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Serotonergic synapse | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Reactome | Serotonin receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | 5-ht5A receptors as a therapeutic target. Pharmacol Ther. 2006 Sep;111(3):707-14. Epub 2006 Mar 6. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.